Search Results - "JUNGE, S"

Long-term effects of a partially supervised conditioning programme in cystic fibrosis by Hebestreit, H, Kieser, S, Junge, S, Ballmann, M, Hebestreit, A, Schindler, C, Schenk, T, Posselt, H-G, Kriemler, S

“…Little is known about the long-term persistence of positive effects induced by a physical conditioning programme in cystic fibrosis. Therefore, this study…”
Get full text

SAGA—a phase Ib/II single-arm, multicenter study of sacituzumab govitecan for patients with metastatic esophagogastric adenocarcinoma by B. Kobitzsch, G. Stocker, U.T. Hacker, S. Junge, C. Pauligk, S.-E. Al-Batran, T.O. Goetze, F. Lordick

“…Background: Treatment of metastatic and locally advanced unresectable esophagogastric adenocarcinoma (EGA) after first-line therapy has limited efficacy…”
Get full text

IPD2.12 Respiratory physiotherapy for children with cystic fibrosis at infancy and early childhood – an actual state-target-analysis in consideration of parental influences on therapy adherence by Junge, S, Gutenbrunner, C, Stein, L, Hellmuth, T

Get full text

Physical activity is independently related to aerobic capacity in cystic fibrosis by Hebestreit, H, Kieser, S, Rudiger, S, Schenk, T, Junge, S, Hebestreit, A, Ballmann, M, Posselt, H-G, Kriemler, S

“…It is unclear whether a relationship between physical activity (PA) and maximal oxygen uptake (V'(O2,max)) exists in cystic fibrosis (CF) and, if so, whether…”
Get full text

A novel sidestream ultrasonic flow sensor for multiple breath washout in children by Fuchs, Susanne I., Sturz, J., Junge, S., Ballmann, M., Gappa, M.

“…Objective Inert gas multiple breath washout (MBW) for measuring Lung Clearance Index using mass spectrometry and 4% sulfur hexafluoride (SF6) as the tracer gas…”
Get full text

WS09.3 Professional quality of life among CF healthcare providers by Goldbeck, L, Fidika, A, Heuer, H.-E, Junge, S, Smaczny, C, Reimann, A

“…Objectives Professional quality of life (ProQOL) is a validated concept used across various helping professions. It appears relevant considering the level of…”
Get full text

ePS05.7 Individual caloric intake in cystic fibrosis (CF) – how to calculate? by Junge, S, Dopfer, C, Stein, L, Kueck, M, Schlüter, K, Stetefeld, A

“…Patients with CF need an individual caloric intake for an optimal nutritional status. Actual guidelines claim a caloric intake of 110% to 200% of the…”
Get full text

Tobramycin once- vs thrice-daily for elective intravenous antipseudomonal therapy in pediatric cystic fibrosis patients by Riethmueller, J, Ballmann, M, Schroeter, T. W, Franke, P, von Butler, R, Claass, A, Junge, S, Doering, G, Stern, M

“…Purpose: We hypothesized that a single intravenous (iv) tobramycine infusion (treatment B) would have equivalent anti-infectious efficacy in chronic…”
Get full text

253 Phase angle (PA) from bioelectrical impedance analysis (BIA) in children with cystic fibrosis (CF) by Junge, S, Stein, L, Schluter, K, Hoyng, C

Get full text

Continuous vs thrice-daily ceftazidime for elective intravenous antipseudomonal therapy in cystic fibrosis by Riethmueller, J, Junge, S, Schroeter, T. W, Kuemmerer, K, Franke, P, Ballmann, M, Claass, A, Broemme, S, Jeschke, R, Hebestreit, A, Staab, D, Koetz, K, Doering, G, Stern, M

“…Background/aim: We hypothesized that a continuous 24-h infusion of 100 mg/kg per day ceftazidime (treatment C) would result in equivalent or even superior…”
Get full text

280 VEMSE-CF: psychosocial characteristics of patients participating in a prospective controlled care research study by Goldbeck, L, Fidika, A, Reimann, A, Hebestreit, H, Heuer, H.-E, Junge, S, Sens, B, Smaczny, C, von der Schulenburg, J.-M

Get full text

Persistent low thymic activity and non-cardiac mortality in children with chromosome 22q11.2 microdeletion and partial DiGeorge syndrome by EBERLE, P, BERGER, C, JUNGE, S, DOUGOUD, S, VALSANGIACOMO BÜCHEL, E, RIEGEL, M, SCHINZEL, A, SEGER, R, GÜNGOR, T

“…A subgroup of patients with 22q11.2 microdeletion and partial DiGeorge syndrome (pDGS) appears to be susceptible to non-cardiac mortality (NCM) despite…”
Get full text

202 Exercise testing in children with cystic fibrosis (CF) – risk for adverse events? by Junge, S, Stein, L, Sörgel, M, School, S, Ballmann, M

Get full text

CF and sport – encouraging the motivation by a specific sport program by Junge, S, Tegtbur, U, Stein, L, Ballmann, M

Get full text

WS19.9 A prospective multicenter study to dissect Staphylococcus aureus-colonization from infection in cystic fibrosis patients by Junge, S, Wiedemann, B, Tümmler, B, Dübbers, A, Küster, P, Nofer, J, Ellemunter, H, Mainz, J.G, Heuer, E, Sextro, W, Körner-Rettberg, C, Ballmann, M, Mellies, U, Hammermann, J, Teschler, H, Szczepanski, R, Tegtmeyer, F.K, Graepler-Mainka, U, Riethmueller, J, Wald, A, Wollschläger, B, Staab, D, Schuster, A, Becker, K, Peters, G, Kahl, B.C

Get full text

Recurrence of PSA after early treatment: a long-term follow-up study by Rebmann, K, Junge, S, Wiehlmann, L, Ballmann, M

Get full text

52 Protein analysis of mutant CFTR in human tissues by van Barneveld, A, Zander, I, Hyde, R, Länger, F, Simon, A, Junge, S, Ballmann, M, Derichs, N, Tümmler, B

Get full text

Persistent low thymic activity and non-cardiac mortality in children with chromosome 22q11·2 microdeletion and partial DiGeorge syndrome by Eberle, P, Berger, C, Junge, S, Dougoud, S, Büchel, E. Valsangiacomo, Riegel, M, Schinzel, A, Seger, R, Güngör, T

“…A subgroup of patients with 22q11·2 microdeletion and partial DiGeorge syndrome (pDGS) appears to be susceptible to non-cardiac mortality (NCM) despite…”
Get full text

WS5.1 Inhaled glutathione in cystic fibrosis by Griese, M, Hector, A, Kappler, M, Ballmann, M, Junge, S, Rietschel, E, Staab, D, van Koningsbruggen, S, Rolinck-Werninghaus, C, Mellis, U, Köhnlein, T, Wagner, T, Cörner-Rettberg, C, Teschler, H, Heuer, E, Kopp, M, Heyder, S, Hammermann, J, Küster, P, Reimann, A, Honer, M, Mansmann, U, Eismann, C

Get full text

TIDES-CF Study: Who participates in psychosocial trials? by Bartig, H.J, Ammon, M, Wünderich, R, Junge, S, Ballmann, M, Ullrich, G

Get full text